PRKAA2 and Alzheimer disease: Further data in support of a detrimental role of AMPK in AD comes from studies showing that treatment of AD mice with the AMPK activator metformin results in transcriptional upregulation of β-secretase, leading to increased Aβ formation and worsened memory [365, 366].